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ABSTRACT  
Background: COPD is characterised by persistent airway obstruction in which better clinical outcome can be attained by appropriate 
management of disease. Adherence to COPD medication is poorly understood due to chronic nature of the disease. It is crucial to identify the 
barriers of non-adherence to build up and execute policies and interventions to upgrade medication adherence. Objective: To identify the 
predisposing barriers of medication adherence and to find the association between medication adherence and variables. Methods: A descriptive 
analytical study was conducted and data was collected from COPD outpatients. The Morisky Medication Adherence Scale was used to measure 
adherence and self-assessed questionnaire was employed to identify the predictors of poor adherence. Chi square test was carried out to find the 
relationship between medication adherence and variables such as age, gender, literacy, socioeconomic class, polypharmacy, del ivery device and 
climate. Results: A total of 403 patients were involved in the study where 68% reported lower adherence. The most common adherence barriers 
found were forgetfulness (88%), intentional stoppage of medicines when symptoms improve (83%) and negligence towards medication (82%).A 
significant association was found between gender, literacy, socioeconomic class, polypharmacy, delivery device and climate. Conclusion: 
Adherence to medication regimen in COPD patients is poor, even though it is a preventable and a treatable disease. Well-structured education, 
training, counseling is required to overcome medication adherence particularly among illiterate and low socioeconomic class patients. The 
combined interventions should be used such as video clips demonstrations of inhaler technique should be given.  
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INTRODUCTION 
Chronic Obstructive Pulmonary Disease (COPD) 
characterizes an imperative general health challenge and is 
the main reason for morbidity and mortality all throughout 
the world. In 2012, a total of 6% deaths were reported 
globally because of the disease. In coming years, COPD 
liability is projected to expand due to constant exposure to 
predisposing factors. As of now, it is the fourth driving 
reason for death in the world yet is anticipated to be the 3rd 
prominent reason for death by 2020.  
In 2003, World Health Organization’s (WHO) Adherence 
Project defines adherence as “the extent to which a person’s 
behavior (taking medication, following a diet, and/or 
executing lifestyle changes) corresponds with agreed 
recommendations from a healthcare provider”.(1) As per 
WHO, patients who were on long term treatment have shown 
50% or less adherence. COPD patients exhibit remarkably 
poor adherence to treatment than asthmatic patients.  (2)   
Underuse, overuse, improper use are the three typical forms 
of medication non-adherence.  
 In order to implement newer policies and disease 
management strategies to enhance medication adherence 
and clinical outcomes, there needs a minimum recognition of 
medication adherence barriers. (3) 
The intention of this study is to identify some of the essential 
perspectives influencing adherence to medication and to 
distinguish certain indicators of poor adherence in COPD 
patients. (2) 
METHODOLOGY 
A descriptive analytical study was carried out in the 
outpatient department of KCG hospital, from October 2018 to 
March 2019. Stable patients more than 40 years old and 
analysed as COPD as indicated by the Global Initiative for 
Chronic Obstructive Lung Disease (GOLD) criteria were 
consecutively incorporated into the research. Patients with 
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psychiatric disorder and those who are not willing to 
participate were not included in the study. The total number 
of COPD patients participated in the study was 403. All 
participants handed out their written informed consent and 
the study was ratified by the Ethics Committee of KLECOP. A 
self -assessed questionnaire on adherence barriers in 
patients was carried out and validated with an indicated 
Cronbach’s alpha of 0.+74. It comprises of 16 items in the 
questionnaire, depicting the determinants of medication 
non-adherence. Adherence was assessed using Morisky 
Medication Adherence Scale which is a 4 item questionnaire 
where the scoring pattern of ‘Yes’ = 0 and ‘No’ = 1 was used. 
The summary score of the MMAS ranges from 0 - 4, in which 
higher scores show more noteworthy adherence. Economic 
and sociologic conditions were measured using 
Kuppuswamy socioeconomic scale, holding the education 
and occupation of the head of the family which gives the 
socioeconomic status of the patients. Association between 
medication adherence and the variables were then analysed. 
RESULT 
 Out of 403 patients participated in the study, there were 
more male patients (59 %) than females (41%). The mean 
age of patients was 63.13 years and greater number of 
patients belonged to age group of 61-70 years (36%). In this 
study 64% of respondents were observed with cigarette 
smoking. The proportion of literate patients were 
significantly higher (67%) compared to illiterate patients 
(33%).Most were identified in the upper lower (42.7%) 
socioeconomic class followed by lower middle (25.5%), 
lower (18.62%) and upper middle (13%) socio economic 
class. Also 257(64%) were administered with multiple 
medications. Furthermore, 47 % of the population used 
inhalers, 32 % used nebulizers while 21% were found to be 
using only oral medications. 
Adherence pattern of 403 patients were measured using 
Morisky Green Levine Scale and it was found that 274 (68%) 
were non adherent while 129 (32%) were adherent to the 
prescribed treatment. According to self-reported 
questionnaire among 274 non-adherent patients, the most 
common cause of non-adherence found were forgetfulness 
(88%) and intentional stoppage of medication use (83%) 
when the symptoms improve. Other reasons include 
negligence towards medication (82%), polypharmacy (56%), 
lack of family support (53%), delay of medication refill from 
pharmacy (48%), refusal of medication use in public (42%). 
Chi-square test was employed to analyse the association 
among adherence and variables where gender, literacy, 
socioeconomic status, polypharmacy, delivery device of 
inhaled medication and climate showed significant 
association.  However there was no association found with 
age groups (p=0.860) 
 
       
Variable Total (n) Adherent (n=129) % Non-adherent (274) % p-value 
Age groups(years) 
40-50 
51-60 
61-70 
71-80 
 
33 
116 
147 
107 
 
10 
39 
49 
31 
 
30  
34  
33  
29  
 
23 
77 
98 
76 
 
70 
66 
67 
71 
 
 
0.860 
GENDER 
Male 
Female 
 
238 
165 
 
61 
68 
 
26 
41 
 
177 
97 
 
74 
59 
 
0.001 
LITERACY 
Literate 
Illiterate 
 
269 
134 
 
109 
20 
 
41 
15 
 
160 
114 
 
59 
85 
 
0.001 
Socioeconomic classes 
Lower 
Upper lower 
Lower middle 
Upper middle 
 
75 
172 
103 
53 
 
13 
47 
43 
26 
 
17 
27 
42 
49 
 
62 
125 
60 
27 
 
83 
73 
58 
51 
 
 
0.001 
Polypharmacy 
Non-polypharmacy 
Polypharmacy 
 
146 
257 
 
79 
50 
 
54 
19 
 
67 
207 
 
46 
81 
 
0.001 
Delivery devices 
Inhaler 
Nebuliser 
No nebulisation or inhaler 
 
191 
127 
85 
 
86 
24 
19 
 
45 
19 
22 
 
105 
103 
66 
 
55 
81 
78 
 
 
0.001 
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Fig 1: Adherence pattern among age group 
 
Fig 2: Adherence pattern among gender 
 
Fig 3: Adherence pattern among literate and illiterate patients 
 
Fig 4: Adherence pattern among socioeconomic classes 
 
Fig 5: Adherence pattern among polypharmacy and non-polypharmacy patients 
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Fig 6: Adherence pattern of medication delivery devices 
 
 
Fig 7: Adherence pattern in relation to climatic conditions. 
 
 
Fig 8: Adherence pattern among gender 
 
 
Fig 9: Percentage of medication adherence barriers 
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DISCUSSION 
Poor adherence to medications often results in increased 
frequency of exacerbations and mortality among COPD 
patients. (4)  In this study with 403 patients, 32% were 
reported adherence to COPD medications while 68% 
reported non adherence which was inconsistent with the 
study by T Agh et al who reported 58.2% of adherence. (5) A 
significant association was found between adherence and 
variables such as gender, literacy, polypharmacy, 
socioeconomic status, delivery devices of inhaled 
medications and climate.  A higher incidence of COPD was 
found in the age group of 60-70 years. According to WHO, the 
occurrence of COPD is common after the age of 40 years and 
increases proportionally with age increments (6)   Among the 
considered age groups, non-adherence was greater in 70-80 
years (71%) which is arguably due to forgetfulness, cognitive 
impairments, complex treatment regimen, lack of family 
support, depression, strong sense of loss and feelings of 
hopelessness.(7) 
Our study showed association between gender and 
adherence as similar to previous studies.(8,9,10) Alcohol 
consumption, smoking, busy schedules, less concerns 
regarding disease and treatment influences medication 
taking behavior within men. This was in controversy with 
the findings of prior studies where female patients showed 
less adherence. Illiterate patients displayed less priority to 
self-care and being part of a minority group and having low 
income resulted in lesser ability to understand medical 
information and label instructions which lead to decreased 
adherence compared to literate patients. (11,12,13,14)  
Furthermore, our results suggests that socioeconomic status 
was significantly associated with adherence where lower 
socioeconomic group showed highest non adherence than 
other groups. In our study most patients were in the older 
population and required complex medications for various 
comorbid conditions which led to frustration and confusion 
and resulted in unintentional non adherence. However J 
Bourbeau illustrated that no significant relation was found 
between polypharmacy and medication adherence. (15)   
The results suggests that 63% of patients were adherent only 
during winter when the symptoms hamper their daily 
functioning while 37% were adherent irrespective of 
seasonal variations. Nebulizers or inhalers were 
recommended to the patients according to the patient 
convenience. In this study 44% of patients were adherent to 
inhalers whereas only 19% were adherent to nebulizer. 
Within the given study facility, the availability of nebulizer 
were free of cost but the patients had to be present in person 
to avail this facility thus they became non-adherent as many 
had commuting difficulty and lack of family support. 
Individuals prescribed with inhalers, which are to be 
obtained from outside the hospital thus making them 
unaffordable to the study population. Moreover, patients 
who have their own inhalers fail to procure refill medications 
which make them equally non-adherent and inconsistent. 
Other plausible reasons for non-adherence to inhalers were 
side effects, forgetfulness and inappropriate inhaler use or 
less confidence in using inhalers. 
Most frequently affecting factors of medication adherence 
were found to be forgetfulness and intentional stoppage of 
medications when symptoms improved which was 
consistent with the study by L Laforest et al , AS Gadkari et al 
A R Fugate et al and I H Galal et al (16,17,18,19) Patients 
misinterpret the lack of clinical symptoms as a cure and go 
for episodic treatment forsaking regular medications hence 
they execute self-treatment and approaches despite the 
instructions given by the healthcare professionals. (15,20) 
Other reasons found from the study were negligence towards 
medication where reasons behind it was lack of seriousness 
to illness or treatment, lack of self- worth, poor insight and 
laziness or lack of care. Subsequently another factor found 
for non-adherence was polypharmacy followed by lack of 
family support which influences their medication taking 
behavior. Other reasons found from the study were 
medication refill delay from pharmacy, refusal of medication 
use in public, feeling of no benefit from treatment, poor 
knowledge about medication burden of disease, beliefs like 
prayer or religious dogmas will help to cure disease, side 
effects (headache, insomnia and nasal congestion) misbeliefs 
regarding treatment, trust issues with health care system.   
Our study is one of the few study to determine the influence 
of socioeconomic status on medication adherence. However 
the study had few limitations. The influence of cost of 
medication on adherence couldn’t be studied as the study 
was conducted in a government hospital and medicines were 
freely dispensed from the pharmacy. Correspondingly the 
time period of the study was limited and medication taking 
behavior of the upper socioeconomic class could not be 
assessed from the study site as the  patients belonging to this 
group consulting in our setting was low.  
CONCLUSION 
In our study, forgetfulness, intentional stoppage of medicines 
when symptoms improve, negligence to medication, 
polypharmacy and inadequate family support were reported 
as the important barriers of medication adherence among 
COPD patients. A significant association was correspondingly 
identified between medication compliance and following 
variables like gender, education, socioeconomic status, 
climate, polypharmacy, and delivery device of inhaled 
medications that influence the adherence to a greater extent. 
Our study was majorly concerned in recognizing the 
medication taking behavior of patients with low 
socioeconomic status where health care providers can play a 
vital role in helping them to overcome the adherence 
barriers. Low literacy patients can be benefitted by 
comprehensive counseling and training involving video clip 
instructions, writings and demonstrations which could be an 
effective method for enhancing health literacy. Education 
emphasizing on benefits of medication adherence and 
enabling the patients for proper inhaler use results in 
improved self -confidence and perception towards disease 
and treatment. Inhaler technique of patient’s should also be 
checked by physicians during every follow up visits and their 
feedbacks should be recorded to enhance adherence. 
Simplified medication regimens with less frequent dosing 
must be recommended to reduce confusion and frustration 
in patients. 
There is a need to develop and implement newer 
amendments as well as procedures in health care system by 
government bodies and organizations to enhance medication 
adherence along with counseling, education or training 
focusing on barriers. 
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